Global Meningococcal Vaccine Market Report By Product (Polysaccharide Vaccines, Conjugate Vaccines, Protein Based Vaccine), By Age Group (Infants, Childem, Adults, Adolescenst & Young Adults), By Distribution Channel (Institutional Sales, Retail Sales) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212373
April 2021
Report Formats:
The global demand for Meningococcal Vaccine Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Meningococcal vaccine helps prevent meningococcal disease. The meningococcal disease is caused by Neisseria meningitides bacteria. The vaccines contain antigens substances that boost the body's immune system and cause it to make antibodies, these antibodies then protect the body by attacking and killing the bacteria. The vaccine is given either by injection into a muscle or just under the skin. There are three types of meningococcal vaccines available: Polysaccharide vaccines, conjugate vaccines, and protein based vaccine.
 
Market Dynamics
 
Growing incidence of meningococcal meningitis isdriving the growth of market. Meningococcal disease is potentially fatal, observed worldwide with reportable condition in all states, but the highest burden of the disease is in the sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east.Market is predicted to experience new waves in the growth owing to the COVID-19, an emerging an rapidly evolving situation.Scientist across the world are focused on discovering vaccine for coronavirus. Various clinical trials are executed to determine the results. Number of drugs and vaccine is identified as candidate to eradicate COVID-19. ChAdOx1 nCoV-19, vaccine against meningococcal disease is among the one. This vaccine acts by priming the immune system to recognize and attack the coronavirus, stimulating a T-cell response and has appeared to be safe in animal and early-stage human testing, giving confidence for the coronavirus version and market growth.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of meningococcal vaccine.
 
Market Segmentation
 
The entire meningococcal vaccine market has been sub-categorized into product, age group, and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Product
  • Polysaccharide Vaccines
  • Conjugate Vaccines
  • Protein Based Vaccine
 
By Age Group
  • Infants
  • Children
  • Adults
  • Adolescenst & Young Adults
 
By Distribution Channel
  • Institutional Sales
  • Retail Sales
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for meningococcal vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Meningococcal Vaccine Market Share by Region (Representative Graph)
 
Global Meningococcal Vaccine Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningococcal vaccine market include GlaxoSmithKline Plc., Novartis International, Serum Institute of India Ltd, Sanofi SA, and Pfizer Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Meningococcal Vaccine Market
       2.2. Global Meningococcal Vaccine Market Snapshot
 
3 . MENINGOCOCCAL VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Meningococcal Vaccine Market
       3.3. Market Restraints of Meningococcal Vaccine Market
       3.4. Opportunities of Meningococcal Vaccine Market
       3.5. Trends of Meningococcal Vaccine Market
       3.6. Porter’s Five Force Analysis of Meningococcal Vaccine Market
       3.7. Meningococcal Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Age Group
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Meningococcal Vaccine Value Chain Analysis
       4.2. Meningococcal Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Meningococcal Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Meningococcal Vaccine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Meningococcal Vaccine Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Meningococcal Vaccine Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Meningococcal Vaccine Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Meningococcal Vaccine Market
 
6 . GLOBAL MENINGOCOCCAL VACCINE MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Global Meningococcal Vaccine Market Analysis by Product
       6.3 Market Analysis of Polysaccharide Vaccines by Regions
       6.4 Market Analysis of Conjugate Vaccines by Regions
       6.6 Market Analysis of Protein Based Vaccine by Regions
 
7 . GLOBAL MENINGOCOCCAL VACCINE MARKET ANALYSIS BY AGE GROUP
       7.1 Overview by Age Group
       7.2 Global Meningococcal Vaccine Market Analysis by Age Group
       7.3 Market Analysis of Infants by Regions
       7.4 Market Analysis of Children by Regions
       7.5 Market Analysis of Adults by Regions
       7.6 Market Analysis of Adolescenst & Young Adults by Regions
 
8 . GLOBAL MENINGOCOCCAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Global Meningococcal Vaccine Market Analysis by Distribution Channel
       8.3 Market Analysis of Institutional Sales by Regions
       8.4 Market Analysis of Retail Sales by Regions
 
9 . GLOBAL MENINGOCOCCAL VACCINE MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Meningococcal Vaccine Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Meningococcal Vaccine Market Estimate by Market Segment
           9.4.3. Europe Meningococcal Vaccine Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Meningococcal Vaccine Market Estimate by Market Segment
           9.5.3. Asia Pacific Meningococcal Vaccine Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Meningococcal Vaccine Market Estimate by Market Segment
           9.6.3. Latin America Meningococcal Vaccine Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Meningococcal Vaccine Market Estimate by Market Segment
           9.7.3. Middle East & Africa Meningococcal Vaccine Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE MENINGOCOCCAL VACCINE COMPANIES
       10.1. Meningococcal Vaccine Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF MENINGOCOCCAL VACCINE INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. GlaxoSmithKline Plc
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Novartis International
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Serum Institute of India Ltd.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Sanofi SA
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Pfizer Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Meningococcal Vaccine Market Snapshot
  • Drivers of The Global Meningococcal Vaccine Market Impact Analysis
  • Restraints of The Global Meningococcal Vaccine Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Meningococcal Vaccine Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Meningococcal Vaccine Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Meningococcal Vaccine Market
  • Global Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Polysaccharide Vaccines by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Conjugate Vaccines by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Protein Based Vaccine by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis by Age Group (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Infants by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Children by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Adults by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Adolescenst & Young Adults by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis by Distribution Channel (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Institutional Sales by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Retail Sales by Geography (USD MN)
  • Global Meningococcal Vaccine Market by Geography (USD MN)
  • North America Meningococcal Vaccine Market Analysis by Product (USD MN)
  • North America Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • North America Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • North America Meningococcal Vaccine Market Estimate by Country (USD MN)
  • United State Meningococcal Vaccine Market Analysis by Product (USD MN)
  • United State Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • United State Meningococcal Vaccine Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Rest of North America Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Rest of North America Meningococcal Vaccine Market Estimate by Distribution Channel(USD MN)
  • Europe Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Europe Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Europe Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Meningococcal Vaccine Market Analysis by Product (USD MN)
  • United Kingdom Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • United Kingdom Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • France Meningococcal Vaccine Market Analysis by Product (USD MN)
  • France Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • France Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Germany Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Germany Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Germany Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Rest of Europe Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Rest of Europe Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Asia Pacific Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Asia Pacific Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Meningococcal Vaccine Market Estimate by Country (USD MN)
  • China Meningococcal Vaccine Market Analysis by Product (USD MN)
  • China Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • China Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Japan Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Japan Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Japan Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • India Meningococcal Vaccine Market Analysis by Product (USD MN)
  • India Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • India Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Rest of Asia Pacific Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Rest of Asia Pacific Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Latin America Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Latin America Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Latin America Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Latin America Meningococcal Vaccine Market Estimate by Country (USD MN)
  • Brazil Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Brazil Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Brazil Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Rest of Latin America Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Rest of Latin America Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Middle East & Africa Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Middle East & Africa Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Meningococcal Vaccine Market Estimate by Country (USD MN)
  • Middle East Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Middle East Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Middle East Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Africa Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Africa Meningococcal Vaccine Market Estimate by Age Group (USD MN)
  • Africa Meningococcal Vaccine Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  • Research Scope of Meningococcal Vaccine Report
  • Market Research Process
  • Market Research Methodology
  • Global Meningococcal Vaccine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Age Group
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Meningococcal Vaccine Market Analysis by Product (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Polysaccharide Vaccines by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Conjugate Vaccines by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Protein Based Vaccine by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis by Age Group (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Infants by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Children by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Adults by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Adolescenst & Young Adults by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis by Distribution Channel (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Institutional Sales by Geography (USD MN)
  • Global Meningococcal Vaccine Market Analysis in Retail Sales by Geography (USD MN)
  • Latin America Meningococcal Vaccine Market by Revenue
  • Middle East & Africa Meningococcal Vaccine Market by Revenue
  • Recent Development in Meningococcal Vaccine Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials